Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 13, 2008 - Issue 3
Submit an article Journal homepage
195
Views
23
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for adrenocortical carcinoma

Alfredo Berruti University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Anna Ferrero University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Paola Sperone University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Fulvia Daffara Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
,
Giuseppe Reimondo Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
,
Mauro Papotti Anatomia Patologica, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026486; +39 0119026992; [email protected]
,
Luigi Dogliotti University of Turin, Department of Clinical and Biological Science, Oncologia Medica, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy +39 0119026512; +39 0119026992; [email protected]
,
Alberto Angeli Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
&
Massimo Terzolo Medicina Interna, Azienda Ospedaliera San Luigi Gonzaga, Orbassano, Italy +39 0119026427; +39 0119026992; [email protected]
 show all
Pages 497-509 | Published online: 02 Sep 2008
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Background: Adrenocortical carcinoma (ACC) is an extremely rare aggressive disease. Few data are available on the efficacy of systemic antineoplastic treatments (mitotane and cytotoxic therapy) in the treatment of advanced disease. Objective/methods: this paper will review the existing treatment strategies and new perspectives in the management of ACC patients. Results/conclusion: An ongoing randomized international trial aims to define the best combination chemotherapy plus mitotane regimen. Based on the results of a case control study, mitotane is being explored as adjuvant therapy. Genetic and biological studies have identified molecular targets for specific targeted drugs such as IGF receptor inhibitors and antiangiogenetic drugs. Phase II trials are exploring the activity of these drugs either alone or in combination with chemotherapy.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,672.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.